Picture of Lineage Cell Therapeutics logo

LCTX — Lineage Cell Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Lineage Cell Therapeutics Posts Q4 Earnings Per Share $0.01

March 11 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL
YEAR
2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * Q4 REVENUE $400,000 VERSUS $1.2 MILLION
    * Q4 EARNINGS PER SHARE $0.01
    * Q4 REVENUE ESTIMATE $817,000 -- REFINITIV IBES DATA
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.05 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nBwbzZqQ8a 
Further company coverage:  LCTX.A 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Lineage Cell Therapeutics

See all news